BR2251 Tablets

· BioRay Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BR2251 Tablets, covering 2026-03-27 to 2026-03-27. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Trial of BR2251 Tablets for Patients With Primary Gout and Hyperuricemia [Phase 2]